Atlas Trials

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

Clinical trial NCT03541928 · RECRUITING

Trial details

NCT number
NCT03541928
Sponsor
The Methodist Hospital Research Institute
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
High-risk Prostate CancerProstate Cancer
Start date
2018-08-02
Primary completion
2023-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.